New and established tyrosine kinase inhibitors for chronic myeloid leukemia.

Thienelt, C D

New and established tyrosine kinase inhibitors for chronic myeloid leukemia. [electronic resource] - Drugs of today (Barcelona, Spain : 1998) Sep 2012 - 601-13 p. digital

Publication Type: Journal Article; Review

1699-3993

10.1358/dot.2012.48.9.1869590 doi


Aniline Compounds--adverse effects
Benzamides
Dasatinib
Humans
Imatinib Mesylate
Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy
Nitriles--adverse effects
Piperazines--adverse effects
Protein Kinase Inhibitors--therapeutic use
Protein-Tyrosine Kinases--antagonists & inhibitors
Pyrimidines--adverse effects
Quinolines--adverse effects
Thiazoles--adverse effects